Funding
FerroptoCure Completes Series A Funding
2025年9月19日
~Accelerating Development of Next-Generation Cancer Therapies Through Ferroptosis Control~FerroptoCure Inc. (H […]
FerroptoCure Selected for the AMED “Strengthening Program for Pharmaceutical Startup Ecosystem”
2025年6月6日
FerroptoCure Inc. (Headquarters: Tokyo, Japan; CEO: Yuji Otsuki) is pleased to announce that it has been selec […]